Loading clinical trials...
Loading clinical trials...
Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial): A Prospective Randomized Controlled Trial
Conditions
Interventions
Protonix (Pantoprazole) 40 mg q 12 hrs for 3 days
Pepcid (Famotidine) 20 mg q 12 hrs for 3 days
Locations
1
United States
Memorial Hermann Texas Medical Center
Houston, Texas, United States
Start Date
January 24, 2025
Primary Completion Date
December 1, 2026
Completion Date
July 1, 2027
Last Updated
May 14, 2025
NCT05806645
NCT07472426
NCT07447791
NCT07106151
NCT07418242
NCT05879432
Lead Sponsor
The University of Texas Health Science Center, Houston
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions